Related Experiment Videos
Introducing evidence-based medicine in reimbursement procedures: does it affect the outcome?
Philippe Van Wilder1, Alain Dupont
1RIZIV National Insurance Agency against Sickness and Disability, Brussels, Belgium. philippe.vanwilder@riziv.fgov.be
Evidence of therapeutic value significantly impacts Belgian pharmaceutical reimbursement decisions. Failing to prove added value increases the odds of a negative decision, while extended evidence decreases them, all within strict timelines.
Area of Science:
- Health Economics
- Pharmaceutical Policy
- Regulatory Science
Background:
- The European Transparency Directive mandates transparent, objective, and timely pharmaceutical reimbursement decisions.
- Member states must adhere to strict timelines for evaluating reimbursement submissions.
Purpose of the Study:
- To assess the influence of therapeutic value evidence on Belgian pharmaceutical reimbursement decisions.
- To determine if therapeutic value evidence impacts decisions without violating strict timelines.
Main Methods:
- Analysis of 824 pharmaceutical reimbursement submissions in Belgium between 2002 and 2004.
- Statistical evaluation of the impact of claimed therapeutic value and evidence type on reimbursement outcomes.
Main Results:
- Only 67 submissions claimed added therapeutic value.
- Failure to prove added value significantly increased the odds of a negative decision (OR = 9.1).
- Submissions with extended evidence (line extensions) had significantly decreased odds of a negative decision (OR = 0.18).
- Median decision time was 175 days, adhering to timelines.
Conclusions:
- Evidence of therapeutic value is a significant factor in Belgian pharmaceutical reimbursement decisions.
- The decision-making process appears to balance evidence assessment with adherence to strict timelines.
Related Concept Videos
Health Information Technology and Healthcare Information System
Health Information Technology, commonly called HIT, integrates advanced information systems and technology in healthcare settings. Its primary functions include:
Drug Products: Biologics, Biosimilars and Interchangeables
Methods of Documentation V: CBE
In CBE, healthcare professionals establish predefined standards of practice that define what constitutes...
Methods of Documentation VI: Case Management Model
For example, a patient with a chronic illness...
Methods of Documentation VII: EMR
Introduction to Documentation and Reporting
Nursing documentation records essential information and details regarding a patient's care and treatment in written or electronic form. It is a critical aspect of nursing practice that involves documenting assessments, interventions, outcomes, and other relevant details about a patient's health status.
Documentation maps the patient's health journey by creating a comprehensive and precise...